Dr. Lawrence Flechner

Dr. Lawrence Flechner
Dr. Lawrence Flechner originally hails from San Francisco. He graduated Phi Beta Kappa from Stanford University, majoring in History—a passion he pursues to this day—while at the same time completing his premedical studies. He then won a coveted scholarship to spend a year researching molecular mechanisms of Cancer at the National Institutes of Health in Bethesda, Maryland. Inspired to connect medical research with patient care, he went on to receive MD and PHD degrees at UCSD and The Salk Institute in La Jolla, California. Under the mentorship of the National Academy Sciences Member Marc Montminy at The Salk, Dr. Flechner made significant advances in our fundamental understanding of sugar metabolism and Diabetes. Specifically, he helped characterize a gene that is essential for blood sugar control. This important work made publication in the prestigious journal Nature. Dr. Flechner’s career next took him to top ranked UCSF Department of Urology, a place of historic significance in shaping the practice of Urology. Dr. Flechner trained under the close mentorship of Doctors Jack McAnanich, Peter Carroll, Marshall Stoller, and Tom Lue, each titans in their respective fields of Urology. At UCSF, Dr. Flechner gained extensive experience in the management of all aspects of benign and oncologic Urology, with expertise and versatility in conventional open, laparoscopic, and robotic surgery. After completing his training in 2012, Dr. Flechner was recruited to become a Partner at the Urology Institute of the South Bay. He is married to a successful leader in Education from Los Angeles, and they have two young children. Dr. Flechner is among the busiest robotic surgeons in the South Bay, and serves on the Robotic Surgery Committee at Torrance Memorial Hospital. A compassionate and dedicated surgeon, he serves on the Advisory Board of the Cancer Support Community of Redondo Beach, and on the Manhattan Beach Rotary Club. When not working, he enjoys organizing family adventures around the world, jogging on the Strand, scuba diving, archaeology, and being a present Dad to his growing kids.

Languages Spoken:

English, Hebrew

Medical School:

UC San Diego


UC San Francisco School of Medicine


Stanford University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only